Related references
Note: Only part of the references are listed.Single-Dose, Placebo-Controlled, Randomized Study of AMG 785, a Sclerostin Monoclonal Antibody
Desmond Padhi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Intermittent PTH(1-34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures
Magnus Tagil et al.
BONE (2010)
Teriparatide for Acceleration of Fracture Repair in Humans: A Prospective, Randomized, Double-Blind Study of 102 Postmenopausal Women With Distal Radial Fractures
Per Aspenberg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Two Doses of Sclerostin Antibody in Cynomolgus Monkeys Increases Bone Formation, Bone Mineral Density, and Bone Strength
Michael S. Ominsky et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Nonoperative Fracture Treatment in the Modern Era
Charles M. Court-Brown et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2010)
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women
Dana Bliuc et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Characterization of the Structural Features and Interactions of Sclerostin MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION
Vaclav Veverka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Thrombospondin-2 Influences the Proportion of Cartilage and Bone During Fracture Healing
Douglas K. Taylor et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Wnt signaling during fracture repair
Frank J. Secreto et al.
Current Osteoporosis Reports (2009)
Beta-catenin-dependent Wnt signaling in mandibular bone regeneration
Philipp Leucht et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Bone regeneration is regulated by Wnt signaling
Jae-Beorn Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys
J. Fox et al.
BONE (2007)
Beta-catenin signaling plays a disparate role in different phases of fracture repair: Implications for therapy to improve bone healing
Yan Chen et al.
PLOS MEDICINE (2007)
Minireview:: Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton
Roland Baron et al.
ENDOCRINOLOGY (2007)
Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys
Takeshi Manabe et al.
BONE (2007)
Risk of subsequent fracture after low-trauma fracture in men and women
Jacqueline R. Center et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Changes in biochemical markers after lower limb fractures
Karl Stoffel et al.
CLINICAL CHEMISTRY (2007)
rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations
H Seeherman et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2006)
Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a non-human primate model
HJ Seeherman et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2004)
Use of bone morphogenetic proteins for musculoskeletal applications - An overview
MA Mont et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2004)
The natural history of sclerosteosis
H Hamersma et al.
CLINICAL GENETICS (2003)
Clinical applications of recombinant human BMPs: Early experience and future development
TA Einhorn
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Van Buchem disease: lifetime evolution of radioclinical features
FM Vanhoenacker et al.
SKELETAL RADIOLOGY (2003)
Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34)
A Nakajima et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Safety profile for the clinical use of bone morphogenetic proteins in the spine
AR Poynton et al.
SPINE (2002)
Age and ovariectomy impair both the normalization of mechanical properties and the accretion of mineral by the fracture callus in rats
RA Meyer et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2001)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys
DB Burr et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)